Teva Pharmaceutical Industries Ltd

Latest stories

17h
Newsmax
Cancer Drug Shortage Leads to Reliance on Chinese Plantavailability, according to the FDA. Companies that have listed a shortage of t
Cancer Drug Shortage Leads to Reliance on Chinese Plant
Newsmax / Posted 17 hours ago
availability, according to the FDA. Companies that have listed a shortage of the component include Pfizer Inc. and Teva Pharmaceutical Industries Ltd. Pfizer said by e-mail that it makes sure its drugs meet standards before reaching the... Read more
3 related stories
3d
Business Wire
Fitch Rates Teva Pharmaceutical's New EUR and CHF Bonds 'BBB'Ratings has assigned 'BBB' ratings to the EUR4 billion and CHF1 billion of new
Fitch Rates Teva Pharmaceutical's New EUR and CHF Bonds 'BBB'
Business Wire / Posted 3 days ago
Ratings has assigned 'BBB' ratings to the EUR4 billion and CHF1 billion of new bonds issued by finance subsidiaries of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; 'BBB'/Stable). Teva previously issued $15 billion of USD-denominated bonds... Read more
3d
The Monterey County Herald
Facing cancer drug shortage, U.S. relies on banned Chinese factoryavailability, according to the FDA. Companies that have listed a shortage of t
Facing cancer drug shortage, U.S. relies on banned Chinese factory
The Monterey County Herald / Posted 3 days ago
availability, according to the FDA. Companies that have listed a shortage of the component include Pfizer Inc. and Teva Pharmaceutical Industries Ltd. Pfizer said by email that it makes sure its drugs meet standards before reaching the... Read more
3 related stories
3d
Santa Cruz Sentinel
Facing cancer drug shortage, U.S. relies on banned Chinese factoryavailability, according to the FDA. Companies that have listed a shortage of t
Facing cancer drug shortage, U.S. relies on banned Chinese factory
Santa Cruz Sentinel / Posted 3 days ago
availability, according to the FDA. Companies that have listed a shortage of the component include Pfizer Inc. and Teva Pharmaceutical Industries Ltd. Pfizer said by email that it makes sure its drugs meet standards before reaching the... Read more
3 related stories
4d
Business Wire
Teva Announces Pricing of Additional CHF1.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsJERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:
Teva Announces Pricing of Additional CHF1.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Generics
Business Wire / Posted 4 days ago
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it successfully priced a debt offering by its special purpose finance subsidiary Teva Pharmaceutical Finance Netherlands IV B.V., consisting of... Read more
4 related stories
4d
Swissinfo
Teva Markets Swiss-Franc Bonds in Worldwide Fundraising Sweep(Bloomberg) -- Teva Pharmaceutical Industries Ltd. is marketing Swiss-franc den
Teva Markets Swiss-Franc Bonds in Worldwide Fundraising Sweep
Swissinfo / Posted 4 days ago
(Bloomberg) -- Teva Pharmaceutical Industries Ltd. is marketing Swiss-franc denominated bonds as the drugmaker sweeps markets worldwide in search of finance for a $40.5 billion acquisition. The Israeli company is selling 1 billion francs ($1... Read more
5d
Business Wire
Fitch Downgrades Teva Pharmaceuticals; Rates New Bonds 'BBB'CHICAGO--(BUSINESS WIRE)--Fitch Ratings has downgraded the ratings of Teva Phar
Fitch Downgrades Teva Pharmaceuticals; Rates New Bonds 'BBB'
Business Wire / Posted 5 days ago
CHICAGO--(BUSINESS WIRE)--Fitch Ratings has downgraded the ratings of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and its subsidiaries, including the Long-Term Issuer Default Rating (IDR), to 'BBB' from 'BBB+' and removed them from Rating Watch... Read more
4 related stories
7d
The Economic Times
Teva Pharma prices $15 bln in notes to fund Allergan generics dealTEL AVIV: Teva Pharmaceutical Industries Ltd said on Tuesday it successfully pr
Teva Pharma prices $15 bln in notes to fund Allergan generics deal
The Economic Times / Posted 7 days ago
TEL AVIV: Teva Pharmaceutical Industries Ltd said on Tuesday it successfully priced a debt offering for $15 billion worth of senior notes to help fund its acquisition of Allergan Plc's generic drug business. The fixed-rate notes mature between 2018... Read more
7d
Business Wire
Teva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsJERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:
Teva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis Generics
Business Wire / Posted 7 days ago
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it successfully priced a debt offering by its special purpose finance subsidiary Teva Pharmaceutical Finance Netherlands III B.V., consisting... Read more
12d
Salon.com
Michaels and Hess slide, Teva and JetBlue trade higherNEW YORK (AP) — Stocks that moved substantially or traded heavily on Wednesday:
Michaels and Hess slide, Teva and JetBlue trade higher
Salon.com / Posted 12 days ago
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Wednesday: Teva Pharmaceutical Industries Ltd. (TEVA), up $2.00 to $54.46 The drugmaker gave strong projections for the second quarter and got closer to completing its purchase of... Read more
2 related stories
12d
Daily Herald
Michaels and Hess slide, Teva and JetBlue trade higherNEW YORK -- Stocks that moved substantially or traded heavily on Wednesday: Te
Michaels and Hess slide, Teva and JetBlue trade higher
Daily Herald / Posted 12 days ago
NEW YORK -- Stocks that moved substantially or traded heavily on Wednesday: Teva Pharmaceutical Industries Ltd. (TEVA), up $2.00 to $54.46 The drugmaker gave strong projections for the second quarter and got closer to completing its purchase of... Read more
2 related stories
12d
FOX Business
Stocks to Watch: FANG, IMPR, AALas capacity also climbed, and the company narrowed its unit revenue forecast. S
Stocks to Watch: FANG, IMPR, AAL
FOX Business / Posted 12 days ago
as capacity also climbed, and the company narrowed its unit revenue forecast. Shares rose 1.27% to $35.10 premarket. Teva Pharmaceutical Industries Ltd. and Allergan PLC on Wednesday said they had tweaked the terms of Teva's purchase of... Read more
2 related stories
12d
FOX Business
Stocks to Watch: FANG, IMPR, AALas capacity also climbed, and the company narrowed its unit revenue forecast. S
Stocks to Watch: FANG, IMPR, AAL
FOX Business / Posted 12 days ago
as capacity also climbed, and the company narrowed its unit revenue forecast. Shares rose 1.27% to $35.10 premarket. Teva Pharmaceutical Industries Ltd. and Allergan PLC on Wednesday said they had tweaked the terms of Teva's purchase of... Read more
2 related stories
13d
Market Watch
Teva raises earnings and revenue guidanceTeva Pharmaceutical Industries Ltd., which is working toward a $40.5 billion ac
Teva raises earnings and revenue guidance
Market Watch / Posted 13 days ago
Teva Pharmaceutical Industries Ltd., which is working toward a $40.5 billion acquisition of Allergan PLC's generics unit, increased its second-quarter earnings and revenue guidance on Tuesday. Teva expects earnings excluding items of $1.19 to $1.22... Read more
2 related stories
18d
TribLIVE
Teva may accelerate bond sale plan | TribLIVE Teva Pharmaceutical Industries Ltd. is weighing plans to accelerat
Teva may accelerate bond sale plan
TribLIVE / Posted 18 days ago
| TribLIVE Teva Pharmaceutical Industries Ltd. is weighing plans to accelerate the sale of $22 billion in bonds because of record-low interest rates, people with knowledge of the matter said. The Israeli company —... Read more
19d
Business Standard India
Aurobindo eyes Teva's product sale in Europein response to a query on Tuesday’s Bloomberg report, which stated the company
Aurobindo eyes Teva's product sale in Europe
Business Standard India / Posted 19 days ago
in response to a query on Tuesday’s Bloomberg report, which stated the company was among other players considering bids for Teva Pharmaceutical Industries Ltd portfolio of drugs in the UK, Ireland and Iceland. The official, however, refused to... Read more
25d
FOX Business
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016side, these headwinds appear to have created some compelling bargains. For exa
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016
FOX Business / Posted 25 days ago
side, these headwinds appear to have created some compelling bargains. For example, AstraZeneca , Seattle Genetics , and Teva Pharmaceutical Industries Ltd. have all fallen by double digits this year, according to data fromS&P Global Market... Read more
25d
FOX Business
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016side, these headwinds appear to have created some compelling bargains. For exa
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016
FOX Business / Posted 25 days ago
side, these headwinds appear to have created some compelling bargains. For example, AstraZeneca , Seattle Genetics , and Teva Pharmaceutical Industries Ltd. have all fallen by double digits this year, according to data fromS&P Global Market... Read more
25d
FOX Business
Chesapeake Partners Shuts Down Citing Government Regulationthis year on Allergan and other companies whose planned mergers were delayed or
Chesapeake Partners Shuts Down Citing Government Regulation
FOX Business / Posted 25 days ago
this year on Allergan and other companies whose planned mergers were delayed or abandoned, including Office Depot Inc and Teva Pharmaceutical Industries Ltd. "From that moment, it has not been possible to invest in pending mergers in the same... Read more
25d
FOX Business
Chesapeake Partners Shuts Down Citing Government Regulationthis year on Allergan and other companies whose planned mergers were delayed or
Chesapeake Partners Shuts Down Citing Government Regulation
FOX Business / Posted 25 days ago
this year on Allergan and other companies whose planned mergers were delayed or abandoned, including Office Depot Inc and Teva Pharmaceutical Industries Ltd. "From that moment, it has not been possible to invest in pending mergers in the same... Read more
1m
Business Wire
Teva Receives CHMP Positive Opinion for CINQAERO® (reslizumab)JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:
Teva Receives CHMP Positive Opinion for CINQAERO® (reslizumab)
Business Wire / Posted a month ago
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing... Read more

People in this news